Johnson & Johnson has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for BALVERSA®▼ (erdafitinib)...
gains
Several researchers from the Niagara Health Knowledge Institute were invited to prominent healthcare conferences in Europe to share their findings...
